Lyrica Capsule
Pricing Report NDC 58151-243-77

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The current wholesale acquisition cost for Lyrica (NDC 58151-243-77) is $9.67301 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Viatris Specialty Llc, this medication is distributed in a 90 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.67301
Per EA

Effective Date
Jun 17, 2026
Billable Units
90 EA
Estimated Package Price
$870.57
Data Status
As of Jul 08, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.05553 (Effective: Jun 17, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2025, the NADAC wholesale price for (NDC ) has moved within a range of $9.67301 to $9.70427 per EA. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.6730 - $9.7043
Market Volatility
0.32% Variance
Latest Trend
0.10%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $9.67301 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.68284 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.67422 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.67745 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.68731 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.68435 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.70427 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.67755 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.68314 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $9.68054 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2025 $9.68369 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2025 $9.68369 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 09, 2025 $9.69086 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026